TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Puerarin, Cisplatin
Phytochemical Name Puerarin (PubChem CID: 5281807 )
Anticancer drug Name Cisplatin (PubChem CID: 5702198 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 78
Pair Name Puerarin, Cisplatin
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Expression CCND1 hsa595
Up-regulation Expression CDH1 hsa999
Down-regulation Expression CTNNB1 hsa1499
Down-regulation Expression MKI67 hsa4288
Down-regulation Expression MMP3 hsa4314
Down-regulation Expression MMP9 hsa4318
Down-regulation Expression MYC hsa4609
Down-regulation Expression PCNA hsa5111
Down-regulation Expression VIM hsa7431
Up-regulation Activity WNT3A hsa89780
In Vitro Model A-549 Lung adenocarcinoma Homo sapiens (Human) CVCL_0023
In Vivo Model Sixty BALB/c nude mice were subcutaneously injected on the right armpit with A549/DDP cell suspensions (1×10⁷/100 mL) and then raised under the standard conditions.
Result Taking these results together, we can draw the conclusion that the PUE enhances the anti-tumor effect of DDP on the drug-resistant A549 cancer in vivo and in vitro through activation of the Wnt signaling pathway.
03. Reference
No. Title Href
1 Puerarin Enhances the Anti-Tumor Effect of Cisplatin on Drug-Resistant A549 Cancer in vivo and in vitro Through Activation of the Wnt Signaling Pathway. Cancer Manag Res. 2020 Jul 24;12:6279-6289. doi: 10.2147/CMAR.S253327. Click
It has been 26220 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP